2020
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial
CIBULA, David, Roman KOCIAN, Andrea PLAIKNER, Jiří JARKOVSKÝ, Jaroslav KLAT et. al.Základní údaje
Originální název
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial
Autoři
CIBULA, David (203 Česká republika, garant), Roman KOCIAN (203 Česká republika), Andrea PLAIKNER (276 Německo), Jiří JARKOVSKÝ (203 Česká republika, domácí), Jaroslav KLAT (203 Česká republika), Ignacio ZAPARDIEL (724 Španělsko), Radovan PILKA (203 Česká republika), Aureli TORNE (724 Španělsko), Borek SEHNAL (203 Česká republika), Marcela OSTOJICH (32 Argentina), Almerinda PETIZ (40 Rakousko), Octavio A. SANCHEZ (724 Španělsko), Jiri PRESL (203 Česká republika), Alessandro BUDA (380 Itálie), Francesco RASPAGLIESI (380 Itálie), Peter KASCAK (703 Slovensko), Luc VAN LONKHUIJZEN (528 Nizozemské království), Marc BARAHONA (724 Španělsko), Luboš MINÁŘ (203 Česká republika, domácí), Pawel BLECHARZ (616 Polsko), Maja PAKIZ (705 Slovinsko), Dariusz WYDRA (616 Polsko), Leon C. SNYMAN (710 Jižní Afrika), Kamil ZALEWSKI (616 Polsko), Cristina ZORRERO (724 Španělsko), Havelka HAVELKA (203 Česká republika), Mikulas REDECHA (703 Slovensko), Alla VINNYTSKA (804 Ukrajina), Ignace VERGOTE (56 Belgie), Solveig TINGULSTAD (578 Norsko), Martin MICHAL (203 Česká republika), Barbara KIPP (756 Švýcarsko), Slama SLAMA (203 Česká republika), Simone MARNITZ (276 Německo), Sylva BAJSOVA (203 Česká republika), Alicia HERNANDEZ (724 Španělsko), Daniela FISCHEROVA (203 Česká republika), Kristyna NEMEJCOVA (203 Česká republika) a Christhardt KOHLER (276 Německo)
Vydání
European Journal of Cancer, Oxford, Elsevier Science Inc. 2020, 0959-8049
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 9.162
Kód RIV
RIV/00216224:14110/20:00116468
Organizační jednotka
Lékařská fakulta
UT WoS
000566726800008
Klíčová slova anglicky
Cervical cancer; Sentinel lymph node; Frozen section; Mapping; Ultrastaging; Micrometastases
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 22. 9. 2020 14:09, Mgr. Tereza Miškechová
Anotace
V originále
Background: SENTIX (ENGOT-CX2/CEEGOG-CX1) is an international, multi centre, prospective observational trial evaluating sentinel lymph node (SLN) biopsy without pelvic lymph node dissection in patients with early-stage cervical cancer. We report the final preplanned analysis of the secondary end-points: SLN mapping and outcomes of intraoperative SLN pathology. Methods: Forty-seven sites (18 countries) with experience of SLN biopsy participated in SENTIX. We preregistered patients with stage IA1/lymphovascular space invasion-positive to IB2 (4 cm or smaller or 2 cm or smaller for fertility-sparing treatment) cervical cancer without suspicious lymph nodes on imaging before surgery. SLN frozen section assessment and pathological ultrastaging were mandatory. Patients were registered postoperatively if SLN were bilaterally detected in the pelvis, and frozen sections were negative. Trial registration: ClinicalTrials.gov (NCT02494063). Results: We analysed data for 395 preregistered patients. Bilateral detection was achieved in 91% (355/395), and it was unaffected by tumour size, tumour stage or body mass index, but it was lower in older patients, in patients who underwent open surgery, and in sites with fewer cases. No SLN were found outside the seven anatomical pelvic regions. Most SLN and positive SLN were localised below the common iliac artery bifurcation. Single positive SLN above the iliac bifurcation were found in 2% of cases. Frozen sections failed to detect 54% of positive lymph nodes (pN1), including 28% of cases with macrometastases and 90% with micrometastases. Interpretation: SLN biopsy can achieve high bilateral SLN detection in patients with tumours of 4 cm or smaller. At experienced centres, all SLN were found in the pelvis, and most were located below the iliac vessel bifurcation. SLN frozen section assessment is an unreliable tool for intraoperative triage because it only detects about half of N1 cases. (C) 2020 The Author(s). Published by Elsevier Ltd.